← Back to Search

Novel, graphene-based, point-of-care device for Coronavirus

N/A
Waitlist Available
Led By Matthew Binnicker, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one hour
Awards & highlights

Study Summary

This trial aims to see if a new device can accurately detect virus infections.

Eligible Conditions
  • Coronavirus
  • Influenza

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and one hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Negative Percent Agreement
Positive Percent Agreement

Trial Design

1Treatment groups
Experimental Treatment
Group I: Novel, graphene-based, point-of-care deviceExperimental Treatment2 Interventions
Subjects will receive one additional nasal swab at the same time as clinical collection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GRIP Electronic Diagnostic Chip
2023
N/A
~50
Laboratory-based nucleic acid amplification tests (NAATs)
2023
N/A
~50

Find a Location

Who is running the clinical trial?

Department of Health and Human ServicesFED
226 Previous Clinical Trials
928,904 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,767,095 Total Patients Enrolled
Matthew Binnicker, PhDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research team have any openings for participants?

"Clinicaltrials.gov does not display any signs that this particular trial is accepting new participants. It was initially posted on February 1st 2023 and last modified on December 21st 2022, however 983 other trials are actively recruiting currently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
Matthew J. Binnicker 2023. "A Study of the GRIP Influenza and SARS-CoV-2 POC Assays". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05674370.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top